• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Charles S. Fuchs, MD, MPH

Publications

  • Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H.Gastric Cancer, Version 2.2013.J Natl Compr Canc Netw. 2013 May 1;11(5):531-546.
    23667204
  • Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA.Localized Colon Cancer, Version 3.2013.J Natl Compr Canc Netw. 2013 May 1;11(5):519-528.
    23667203
  • Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J.Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women.Sleep. 2013;36(5):681-8.
    23633750
  • Yamauchi M, Lochhead P, Imamura Y, Kuchiba A, Liao X, Qian ZR, Nishihara R, Morikawa T, Shima K, Wu K, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT, Ogino S.Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer.Cancer Epidemiol Biomarkers Prev. 2013 Apr 29.
    23629521
  • Zhang X, Wu K, Cho E, Ma J, Chan AT, Gao X, Willett WC, Fuchs CS, Giovannucci EL.Prospective cohort studies of bowel movement frequency and laxative use and colorectal cancer incidence in US women and men.Cancer Causes Control. 2013 May;24(5):1015-24.
    23456271
  • Wolpin BM, Ng K, Zhu AX, Abrams T, Enzinger PC, McCleary NJ, Schrag D, Kwak EL, Allen JN, Bhargava P, Chan JA, Goessling W, Blaszkowsky LS, Supko JG, Elliot M, Sato K, Regan E, Meyerhardt JA, Fuchs CS.Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.Oncologist. 2013 Apr 11.
    23580238
  • Bao Y, Giovannucci EL, Kraft P, Qian ZR, Wu C, Ogino S, Gaziano JM, Stampfer MJ, Ma J, Buring JE, Sesso HD, Lee IM, Rifai N, Pollak MN, Jiao L, Lessin L, Cochrane BB, Manson JE, Fuchs CS, Wolpin BM.Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts.Cancer Epidemiol Biomarkers Prev. 2013 Apr 10.
    23462920
  • Strosberg J, Chan J, Ryan DP, Meyerhardt JA, Fuchs CS, Abrams TA, Regan EM, Brady R, Weber J, Campos T, Kvols L, Kulke MH.A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.Endocr. Relat. Cancer. 2013 Apr 9.
    23572164
  • Rubinson DA, Hochster HS, Ryan DP, Wolpin BM, McCleary NJ, Abrams TA, Chan JA, Iqbal S, Lenz HJ, Lim D, Rose J, Bekaii-Saab T, Chen HX, Fuchs CS, Ng K.Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.Invest New Drugs. 2013 Apr 9.
    23568716
  • Nan H, Giovannucci EL, Wu K, Selhub J, Paul L, Rosner B, Fuchs CS, Cho E.Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women.PLoS ONE. 2013;8(4):e59455.
    23560049
  • Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L.A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk.Pancreas. 2013 Mar;42(2):209-15.
    23295781
  • Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E.Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.Mod Pathol. 2013 Apr;26(4):465-84.
    23307060
  • Lee MS, Mamon HJ, Hong TS, Choi NC, Fidias PM, Kwak EL, Meyerhardt JA, Ryan DP, Bueno R, Donahue DM, Jaklitsch MT, Lanuti M, Rattner DW, Fuchs CS, Enzinger PC.Preoperative cetuximab, irinotecan, Cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.Oncologist. 2013;18(3):281-7.
    23429739
  • Ter-Minassian M, Chan JA, Hooshmand SM, Brais LK, Daskalova A, Heafield R, Buchanan L, Qian ZR, Fuchs CS, Lin X, Christiani DC, Kulke MH.Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.Endocr. Relat. Cancer. 2013;20(2):187-96.
    23319495
  • Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Duggan D, Edwards T, Fuchs CS, Gallinger S, Giovannucci EL, Gogarten SM, Gruber SB, Haile RW, Harrison TA, Hayes RB, Henderson BE, Hoffmeister M, Hopper JL, Hudson TJ, Hunter DJ, Jackson RD, Jee SH, Jenkins MA, Jia WH, Kolonel LN, Kooperberg C, Küry S, Lacroix AZ, Laurie CC, Laurie CA, Le Marchand L, Lemire M, Levine D, Lindor NM, Liu Y, Ma J, Makar KW, Matsuo K, Newcomb PA, Potter JD, Prentice RL, Qu C, Rohan T, Rosse SA, Schoen RE, Seminara D, Shrubsole M, Shu XO, Slattery ML, Taverna D, Thibodeau SN, Ulrich CM, White E, Xiang Y, Zanke BW, Zeng YX, Zhang B, Zheng W, Hsu L, .Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis.Gastroenterology. 2013 Apr;144(4):799-807.e24.
    23266556
  • Lin JH, Zhang SM, Rexrode KM, Manson JE, Chan AT, Wu K, Tworoger SS, Hankinson SE, Fuchs C, Gaziano JM, Buring JE, Giovannucci E.Association between sex hormones and colorectal cancer risk in men and women.Clin Gastroenterol Hepatol. 2013 Apr;11(4):419-424.e1.
    23200979
  • Je Y, Lee JE, Ma J, Zhang X, Cho E, Rosner B, Selhub J, Fuchs CS, Meyerhardt J, Giovannucci E.Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer.Cancer Causes Control. 2013 Apr;24(4):719-29.
    23340905
  • Zhu AX, Ancukiewicz M, Supko JG, Sahani DV, Blaszkowsky LS, Meyerhardt JA, Abrams TA, McCleary NJ, Bhargava P, Muzikansky A, Sheehan S, Regan E, Vasudev E, Knowles M, Fuchs CS, Ryan DP, Jain RK, Duda DG.Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.Clin Cancer Res. 2013 Mar 15;19(6):1557-66.
    23362324
  • Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y, Liao X, Qian ZR, Ng K, Chan AT, Meyerhardt JA, Giovannucci E, Fuchs CS, Ogino S.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Cancer Res. 2013 Mar 1;73(5):1600-10.
    23442321
  • Meng S, Zhang X, Giovannucci EL, Ma J, Fuchs CS, Cho E.No association between garlic intake and risk of colorectal cancer.Cancer Epidemiology. 2013 Apr;37(2):152-5.
    23265869
  • Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA.Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152.
    23411381
  • Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Yu K, Wolpin BM, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovanucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman-Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Tjønneland A, Trichopoulos D, Virtamo J, Visvanathan K, Elena JW, Yu H, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ.Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4.Cancer Causes Control. 2013 Mar;24(3):595-602.
    23334854
  • McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, Enzinger P, Ng K, Wolpin B, Schrag D, Fuchs CS, Hurria A, Meyerhardt JA.Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.Oncologist. 2013;18(1):64-72.
    23287880
  • Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, Manson JE, Fuchs CS, Wolpin BM.A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.Journal of the National Cancer Institute. 2013 Jan 16;105(2):95-103.
    23243202
  • Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA.Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405.Clin Colorectal Cancer. 2013 Jan 11.
    23317558
  • Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD.Restriction of intestinal stem cell expansion and the regenerative response by YAP.Nature. 2013 Jan 3;493(7430):106-10.
    23178811
  • Benson AB, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Sofocleous CT, Venook AP, Willett CG, Freedman-Cass DA, Gregory KM.Rectal cancer.J Natl Compr Canc Netw. 2012 Dec 1;10(12):1528-64.
    23221790
  • Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F, Cao G, Duell EJ, Elena JW, Gaziano JM, Giovannucci EL, Hallmans G, Hutchinson A, Hunter DJ, Jenab M, Jiang G, Khaw KT, Lacroix A, Li Z, Mendelsohn JB, Panico S, Patel AV, Qian ZR, Riboli E, Sesso H, Shen H, Shu XO, Tjonneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Wactawski-Wende J, Wang C, Yu K, Zeleniuch-Jacquotte A, Chanock S, Hoover R, Hartge P, Fuchs CS, Lin D, Wolpin BM.Genome-wide association study of survival in patients with pancreatic adenocarcinoma.Gut. 2012 Nov 24.
    23180869
  • Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T, Yamauchi M, Liao X, Qian ZR, Sun R, Sato K, Kirkner GJ, Wang M, Spiegelman D, Meyerhardt JA, Schernhammer ES, Chan AT, Giovannucci E, Fuchs CS.Prospective Study of Family History and Colorectal Cancer Risk by Tumor LINE-1 Methylation Level.Journal of the National Cancer Institute. 2012 Nov 21.
    23175808
  • Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS.Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803.Journal of the National Cancer Institute. 2012 Nov 21;104(22):1702-11.
    23136358
  • Lochhead P, Imamura Y, Morikawa T, Kuchiba A, Yamauchi M, Liao X, Qian ZR, Nishihara R, Wu K, Meyerhardt JA, Fuchs CS, Ogino S.Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.Eur J Cancer. 2012 Dec;48(18):3405-13.
    22840368
  • Waldron L, Ogino S, Hoshida Y, Shima K, McCart Reed AE, Simpson PT, Baba Y, Nosho K, Segata N, Vargas AC, Cummings MC, Lakhani SR, Kirkner GJ, Giovannucci E, Quackenbush J, Golub TR, Fuchs CS, Parmigiani G, Huttenhower C.Expression Profiling of Archival Tumors for Long-term Health Studies.Clin Cancer Res. 2012 Nov 15;18(22):6136-6146.
    23136189
  • Garcia-Albeniz X, Nan H, Valeri L, Morikawa T, Kuchiba A, Phipps AI, Hutter CM, Peters U, Newcomb PA, Fuchs CS, Giovannucci EL, Ogino S, Chan AT.Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.Carcinogenesis. 2012 Nov 8.
    23104301
  • Gong J, Hutter C, Baron JA, Berndt S, Caan B, Campbell PT, Casey G, Chan AT, Cotterchio M, Fuchs CS, Gallinger S, Giovannucci E, Harrison T, Hayes R, Hsu L, Jiao S, Lin Y, Lindor NM, Newcomb P, Pflugeisen B, Phipps AI, Rohan T, Schoen R, Seminara D, Slattery ML, Stelling D, Thomas F, Warnick G, White E, Potter J, Peters U.A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors.Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1974-85.
    23001243
  • Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Kraft P, Mendelsohn JB, Michaud DS, Palli D, Phillips LS, Overvad K, Patel AV, Sansbury L, Shu XO, Simon MS, Slimani N, Trichopoulos D, Visvanathan K, Virtamo J, Wolpin BM, Zeleniuch-Jacquotte A, Fuchs CS, Hoover RN, Gross M.Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.Cancer Causes Control. 2012 Oct 31.
    23112111
  • Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S.Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.N Engl J Med. 2012 Oct 25;367(17):1596-606.
    23094721
  • Morikawa T, Tanaka N, Kuchiba A, Nosho K, Yamauchi M, Hornick JL, Swanson RS, Chan AT, Meyerhardt JA, Huttenhower C, Schrag D, Fuchs CS, Ogino S.Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies.Arch Surg. 2012 Aug;147(8):715-23.
    22508672
  • Zhang X, Lee JE, Ma J, Je Y, Wu K, Willett WC, Fuchs CS, Giovannucci EL.Prospective cohort studies of vitamin B-6 intake and colorectal cancer incidence: modification by time?.Am J Clin Nutr. 2012 Oct;96(4):874-81.
    22875713
  • Chan JA, Ryan DP, Zhu AX, Abrams TA, Wolpin BM, Malinowski P, Regan EM, Fuchs CS, Kulke MH.Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors.Endocr. Relat. Cancer. 2012 Oct;19(5):615-23.
    22736724
  • Khalili H, Huang ES, Ogino S, Fuchs CS, Chan AT.A prospective study of bisphosphonate use and risk of colorectal cancer.J Clin Oncol. 2012 Sep 10;30(26):3229-33.
    22649131
  • Imamura Y, Morikawa T, Liao X, Lochhead P, Kuchiba A, Yamauchi M, Qian ZR, Nishihara R, Meyerhardt JA, Haigis KM, Fuchs CS, Ogino S.Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.Clin Cancer Res. 2012 Sep 1;18(17):4753-63.
    22753589
  • Koushik A, Spiegelman D, Albanes D, Anderson KE, Bernstein L, van den Brandt PA, Bergkvist L, English DR, Freudenheim JL, Fuchs CS, Genkinger JM, Giles GG, Goldbohm RA, Horn-Ross PL, Männistö S, McCullough ML, Millen AE, Miller AB, Robien K, Rohan TE, Schatzkin A, Shikany JM, Stolzenberg-Solomon RZ, Willett WC, Wolk A, Ziegler RG, Smith-Warner SA.Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies.Am J Epidemiol. 2012 Sep 1;176(5):373-86.
    22875754
  • Chan JA, Stuart K, Earle CC, Clark JW, Bhargava P, Miksad R, Blaszkowsky L, Enzinger PC, Meyerhardt JA, Zheng H, Fuchs CS, Kulke MH.Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.J Clin Oncol. 2012 Aug 20;30(24):2963-8.
    22778320
  • Ogino S, Fuchs CS, Giovannucci E.How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.Expert Rev Mol Diagn. 2012 Jul;12(6):621-8.
    22845482
  • Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu XO, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ.Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.Carcinogenesis. 2012 Jul;33(7):1384-90.
    22523087
  • Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Reid JG, Santibanez J, Shinbrot E, Trevino LR, Wu YQ, Wang M, Gunaratne P, Donehower LA, Creighton CJ, Wheeler DA, Gibbs RA, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, Getz G, Ding L, Fulton RS, Koboldt DC, Wylie T, Walker J, Dooling DJ, Fulton L, Delehaunty KD, Fronick CC, Demeter R, Mardis ER, Wilson RK, Chu A, Chun HJ, Mungall AJ, Pleasance E, Robertson A, Stoll D, Balasundaram M, Birol I, Butterfield YS, Chuah E, Coope RJ, Dhalla N, Guin R, Hirst C, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA, Schein JE, Slobodan JR, Tam A, Thiessen N, Varhol R, Zeng T, Zhao Y, Jones SJ, Marra MA, Bass AJ, Ramos AH, Saksena G, Cherniack AD, Schumacher SE, Tabak B, Carter SL, Pho NH, Nguyen H, Onofrio RC, Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Getz G, Meyerson M, Protopopov A, Zhang J, Hadjipanayis A, Lee E, Xi R, Yang L, Ren X, Zhang H, Sathiamoorthy N, Shukla S, Chen PC, Haseley P, Xiao Y, Lee S, Seidman J, Chin L, Park PJ, Kucherlapati R, Auman JT, Hoadley KA, Du Y, Wilkerson MD, Shi Y, Liquori C, Meng S, Li L, Turman YJ, Topal MD, Tan D, Waring S, Buda E, Walsh J, Jones CD, Mieczkowski PA, Singh D, Wu J, Gulabani A, Dolina P, Bodenheimer T, Hoyle AP, Simons JV, Soloway M, Mose LE, Jefferys SR, Balu S, O'Connor BD, Prins JF, Chiang DY, Hayes D, Perou CM, Hinoue T, Weisenberger DJ, Maglinte DT, Pan F, Berman BP, Van Den Berg DJ, Shen H, Triche T Jr, Baylin SB, Laird PW, Getz G, Noble M, Voet D, Saksena G, Gehlenborg N, DiCara D, Zhang J, Zhang H, Wu CJ, Liu SY, Shukla S, Lawrence MS, Zhou L, Sivachenko A, Lin P, Stojanov P, Jing R, Park RW, Nazaire MD, Robinson J, Thorvaldsdottir H, Mesirov J, Park PJ, Chin L, Thorsson V, Reynolds SM, Bernard B, Kreisberg R, Lin J, Iype L, Bressler R, Erkkilä T, Gundapuneni M, Liu Y, Norberg A, Robinson T, Yang D, Zhang W, Shmulevich I, de Ronde JJ, Schultz N, Cerami E, Ciriello G, Goldberg AP, Gross B, Jacobsen A, Gao J, Kaczkowski B, Sinha R, Aksoy B, Antipin Y, Reva B, Shen R, Taylor BS, Chan TA, Ladanyi M, Sander C, Akbani R, Zhang N, Broom BM, Casasent T, Unruh A, Wakefield C, Hamilton SR, Cason R, Baggerly KA, Weinstein JN, Haussler D, Benz CC, Stuart JM, Benz SC, Sanborn J, Vaske CJ, Zhu J, Szeto C, Scott GK, Yau C, Ng S, Goldstein T, Ellrott K, Collisson E, Cozen AE, Zerbino D, Wilks C, Craft B, Spellman P, Penny R, Shelton T, Hatfield M, Morris S, Yena P, Shelton C, Sherman M, Paulauskis J, Gastier-Foster JM, Bowen J, Ramirez NC, Black A, Pyatt R, Wise L, White P, Bertagnolli M, Brown J, Chan TA, Chu GC, Czerwinski C, Denstman F, Dhir R, Dörner A, Fuchs CS, Guillem JG, Iacocca M, Juhl H, Kaufman A, Kohl B 3rd, Van Le X, Mariano MC, Medina EN, Meyers M, Nash GM, Paty PB, Petrelli N, Rabeno B, Richards WG, Solit D, Swanson P, Temple L, Tepper JE, Thorp R, Vakiani E, Weiser MR, Willis JE, Witkin G, Zeng Z, Zinner MJ, Zornig C, Jensen MA, Sfeir R, Kahn AB, Chu AL, Kothiyal P, Wang Z, Snyder EE, Pontius J, Pihl TD, Ayala B, Backus M, Walton J, Whitmore J, Baboud J, Berton DL, Nicholls MC, Srinivasan D, Raman R, Girshik S, Kigonya PA, Alonso S, Sanbhadti RN, Barletta SP, Greene JM, Pot DA, Shaw KR, Dillon LA, Buetow K, Davidsen T, Demchok JA, Eley G, Ferguson M, Fielding P, Schaefer C, Sheth M, Yang L, Guyer MS, Ozenberger BA, Palchik JD, Peterson J, Sofia HJ, Thomson E.Comprehensive molecular characterization of human colon and rectal cancer.Nature. 2012 Jul 18;487(7407):330-7.
    22810696
  • Zhang X, Ma J, Wu K, Chan AT, Fuchs CS, Giovannucci EL.Blood donation and colorectal cancer incidence and mortality in men.PLoS ONE. 2012;7(6):e39319.
    22761761
  • Brooks GA, Enzinger PC, Fuchs CS.Adjuvant therapy for gastric cancer: revisiting the past to clarify the future.J Clin Oncol. 2012 Jul 1;30(19):2297-9.
    22585690
  • Phipps AI, Newcomb PA, Garcia-Albeniz X, Hutter CM, White E, Fuchs CS, Hazra A, Ogino S, Nan H, Ma J, Campbell PT, Figueiredo JC, Peters U, Chan AT.Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer.Gastroenterology. 2012 Jul;143(1):51-4.e4.
    22580541
  • Morikawa T, Shima K, Kuchiba A, Yamauchi M, Tanaka N, Imamura Y, Liao X, Qian ZR, Brahmandam M, Longtine JA, Lindeman NI, Fuchs CS, Ogino S.No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from h&e-stained archival tissue sections.Am J Clin Pathol. 2012 Jul;138(1):122-9.
    22706867
  • Lin JH, Morikawa T, Chan AT, Kuchiba A, Shima K, Nosho K, Kirkner G, Zhang SM, Manson JE, Giovannucci E, Fuchs CS, Ogino S.Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression.Cancer Res. 2012 Jun 15;72(12):3020-8.
    22511578
  • Cella D, Butt Z, Kindler HL, Fuchs CS, Bray S, Barlev A, Oglesby A.Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer.Qual Life Res. 2012 Jun 8.
    22678353
  • Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, Taylor PR, Freedman ND, Abnet CC, Goldstein AM, Hu N, Yu K, Yuan JM, Liao L, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Aldrich MC, Amos C, Blot WJ, Bock CH, Gillanders EM, Harris CC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, McNeill LH, Rybicki BA, Schwartz AG, Signorello LB, Spitz MR, Wiencke JK, Wrensch M, Wu X, Zanetti KA, Ziegler RG, Figueroa JD, Garcia-Closas M, Malats N, Marenne G, Prokunina-Olsson L, Baris D, Schwenn M, Johnson A, Landi MT, Goldin L, Consonni D, Bertazzi PA, Rotunno M, Rajaraman P, Andersson U, Beane Freeman LE, Berg CD, Buring JE, Butler MA, Carreon T, Feychting M, Ahlbom A, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Hartge P, Henriksson R, Inskip PD, Johansen C, Landgren A, McKean-Cowdin R, Michaud DS, Melin BS, Peters U, Ruder AM, Sesso HD, Severi G, Shu XO, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Silverman DT, Kogevinas M, Gonzalez JR, Villa O, Li D, Duell EJ, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Hassan M, Wheeler W, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross MD, Holly EA, Klein AP, LaCroix A, Mandelson MT, Petersen G, Boutron-Ruault MC, Bracci PM, Canzian F, Chang K, Cotterchio M, Giovannucci EL, Goggins M, Hoffman Bolton JA, Jenab M, Khaw KT, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Rabe KG, Riboli E, Tjønneland A, Tobias GS, Trichopoulos D, Elena JW, Yu H, Amundadottir L, Stolzenberg-Solomon RZ, Kraft P, Schumacher F, Stram D, Savage SA, Mirabello L, Andrulis IL, Wunder JS, Patiño García A, Sierrasesúmaga L, Barkauskas DA, Gorlick RG, Purdue M, Chow WH, Moore LE, Schwartz KL, Davis FG, Hsing AW, Berndt SI, Black A, Wentzensen N, Brinton LA, Lissowska J, Peplonska B, McGlynn KA, Cook MB, Graubard BI, Kratz CP, Greene MH, Erickson RL, Hunter DJ, Thomas G, Hoover RN, Real FX, Fraumeni JF, Caporaso NE, Tucker M, Rothman N, Pérez-Jurado LA, Chanock SJ.Detectable clonal mosaicism and its relationship to aging and cancer.Nat Genet. 2012 Jun;44(6):651-8.
    22561519
  • Jacobson BC, Giovannucci EL, Fuchs CS.Smoking and Barrett's Esophagus in Women Who Undergo Upper Endoscopy.Dig Dis Sci. 2011 Mar 30.
    21448698
  • Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, Chan AT, Giovannucci E, Fuchs CS, Ogino S.Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.Cancer. 2011 Apr 1;117(7):1399-408.
    21425139
  • Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS.Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741.J Clin Oncol. 2011 Mar 21.
    21422438
  • Lee JE, Willett WC, Fuchs CS, Smith-Warner SA, Wu K, Ma J, Giovannucci E.Folate intake and risk of colorectal cancer and adenoma: modification by time.Am J Clin Nutr. 2011 Apr;93(4):817-25.
    21270374
  • Khalili H, Wolpin BM, Huang ES, Giovannucci E, Kraft P, Fuchs CS, Chan AT.ABO Blood Group and Risk of Colorectal Cancer.Cancer Epidemiol Biomarkers Prev. 2011 Mar 17.
    21415359
  • Morikawa T, Baba Y, Yamauchi M, Kuchiba A, Nosho K, Shima K, Tanaka N, Huttenhower C, Frank DA, Fuchs CS, Ogino S.STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers.Clin Cancer Res. 2011 Mar 15;17(6):1452-62.
    21310826
  • Chan AT, Ogino S, Giovannucci EL, Fuchs CS.Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.Gastroenterology. 2011 Mar;140(3):799-808.e2.
    21115010
  • Ogino S, Chan AT, Fuchs CS, Giovannucci E.Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.Gut. 2011 Mar;60(3):397-411. Review.
    21036793
  • Shima K, Morikawa T, Baba Y, Nosho K, Suzuki M, Yamauchi M, Hayashi M, Giovannucci E, Fuchs CS, Ogino S.MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.Cancer Causes Control. 2011 Feb;22(2):301-9.
    21140203
  • Chan JA, Blaszkowsky LS, Enzinger PC, Ryan DP, Abrams TA, Zhu AX, Temel JS, Schrag D, Bhargava P, Meyerhardt JA, Wolpin BM, Fidias P, Zheng H, Florio S, Regan E, Fuchs CS.A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma.Ann Oncol. 2011 Jan 7.
    21217058
  • Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.Int J Cancer. 2011 Mar 1;128(5):1080-94.
    20473920
  • Mamon HJ, Niedzwiecki D, Hollis D, Tan BR, Mayer RJ, Tepper JE, Goldberg RM, Blackstock AW, Fuchs CS, .A phase 2 trial of gemcitabine, 5-florouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003.Cancer. 2010 Dec 23.
    21184523
  • Bao Y, Nimptsch K, Meyerhardt J, Chan AT, Ng K, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E, Fuchs CS.Dietary insulin load, dietary insulin index, and colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3020-6.
    20924099
  • Wolpin BM, Kraft PL, Xu M, Steplowski E, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, Myron G, Helzlsouer K, Jacobs EJ, Lacroix A, Gloria P, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Allen NE, Amundadottir L, Austin MA, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Gaziano JM, Giovannucci E, Hallmans G, Hankinson SE, Hoover RN, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Mendelsohn J, Michaud DS, Overvad K, Patel AV, Sanchez MJ, Sansbury LB, Shu XO, Slimani N, Tobias GS, Trichopoulos D, Vineis P, Visvanathan K, Virtamo J, Wactawski-Wende J, Watters JL, Yu K, Zeleniuch-Jacquotte A, Hartge P, Fuchs CS.Variant ABO Blood Group Alleles, Secretor Status and Risk of Pancreatic Cancer: Results from the Pancreatic Cancer Cohort Consortium.Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3140-9.
    20971884
  • Baba Y, Nosho K, Shima K, Huttenhower C, Tanaka N, Hazra A, Giovannucci EL, Fuchs CS, Ogino S.Hypomethylation of the IGF2 DMR in Colorectal Tumors, Detected by Bisulfite Pyrosequencing, Is Associated With Poor Prognosis.Gastroenterology. 2010 Dec;139(6):1855-64.
    20682317
  • Tanaka N, Huttenhower C, Nosho K, Baba Y, Shima K, Quackenbush J, Haigis KM, Giovannucci E, Fuchs CS, Ogino S.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer.Am J Pathol. 2010 Dec;177(6):2731-40.
    21037082
  • Fung TT, Hu FB, Wu K, Chiuve SE, Fuchs CS, Giovannucci E.The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer.Am J Clin Nutr. 2010 Dec;92(6):1429-35.
    21097651
  • Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson SC, Leitzmann M, Männistö S, Marshall JR, Miller AB, Patel AV, Rohan TE, Stolzenberg-Solomon RZ, Verhage BA, Virtamo J, Willcox BJ, Wolk A, Ziegler RG, Smith-Warner SA.A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk.Int J Cancer. 2010 Nov 23.
    21105029
  • Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, Chan AT, Giovannucci E, Fuchs CS, Ogino S.Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.Cancer. 2010 Nov 8.
    21061337
  • Chan AT, Baba Y, Shima K, Nosho K, Chung DC, Hung KE, Mahmood U, Madden K, Poss K, Ranieri A, Shue D, Kucherlapati R, Fuchs CS, Ogino S.Cathepsin B Expression and Survival in Colon Cancer: Implications for Molecular Detection of Neoplasia.Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2777-85.
    20833970
  • Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.J Pathol. 2010 Dec;222(4):350-66.
    20927778
  • Kulke MH, Chan JA, Meyerhardt JA, Zhu AX, Abrams TA, Blaszkowsky LS, Regan E, Sidor C, Fuchs CS.A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.Cancer Chemother Pharmacol. 2010 Oct 20.
    20960192
  • Ng K, Meyerhardt JA, Chan JA, Niedzwiecki D, Hollis DR, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Fuchs CS.Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.J Clin Oncol. 2010 Oct 1;28(28):4354-63.
    20805450
  • Baba Y, Nosho K, Shima K, Meyerhardt JA, Chan AT, Engelman JA, Cantley LC, Loda M, Giovannucci E, Fuchs CS, Ogino S.Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Br J Cancer. 2010 Sep 28;103(7):1025-33.
    20808308
  • Zhu AX, Duda DG, Ancukiewicz M, di Tomaso E, Clark JW, Miksad R, Fuchs CS, Ryan DP, Jain RK.Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: Kinetics and potential biomarker value.Clin Cancer Res. 2010 Sep 15.
    20843836
  • Irahara N, Baba Y, Nosho K, Shima K, Yan L, Dias-Santagata D, Iafrate AJ, Fuchs CS, Haigis KM, Ogino S.NRAS mutations are rare in colorectal cancer.Diagn Mol Pathol. 2010 Sep;19(3):157-63.
    20736745
  • Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, Amundadottir L, Boutron-Ruault MC, Buring JE, Canzian F, Clipp S, Dorronsoro M, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Jacobs KB, Jenab M, Kraft P, Kooperberg C, Lynch SM, Sund M, Mendelsohn JB, Mouw T, Newton CC, Overvad K, Palli D, Peeters PH, Rajkovic A, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A.Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).Int J Cancer. 2010 Sep 1;127(6):1421-8.
    20049842
  • Mekary RA, Wu K, Giovannucci E, Sampson L, Fuchs C, Spiegelman D, Willett WC, Smith-Warner SA.Total antioxidant capacity intake and colorectal cancer risk in the Health Professionals Follow-up Study.Cancer Causes Control. 2010 Aug;21(8):1315-21.
    20390446
  • Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, Wactawski-Wende J, Arslan AA, Bas Bueno-de-Mesquita H, Fuchs CS, Gross M, Helzlsouer K, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Allen N, Ammundadottir L, Bergmann MM, Boffetta P, Buring JE, Canzian F, Chanock SJ, Clavel-Chapelon F, Clipp S, Freiberg MS, Michael Gaziano J, Giovannucci EL, Hankinson S, Hartge P, Hoover RN, Allan Hubbell F, Hunter DJ, Hutchinson A, Jacobs K, Kooperberg C, Kraft P, Manjer J, Navarro C, Peeters PH, Shu XO, Stevens V, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Tumino R, Vineis P, Virtamo J, Wallace R, Wolpin BM, Yu K, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ.Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).Cancer Causes Control. 2010 Aug;21(8):1213-25.
    20373013
  • McLeod HL, Sargent DJ, Marsh S, Green EM, King CR, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Thibodeau SN, Grothey A, Morton RF, Goldberg RM.Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.J Clin Oncol. 2010 Jul 10;28(20):3227-33.
    20530282
  • Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS, Ogino S.Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.Mol Cancer. 2010;9:125.
    20507599
  • Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs C, Ogino S.Dietary Folate, Alcohol, and B Vitamins in Relation to LINE-1 Hypomethylation in Colon Cancer.Gut. 2010 Jun;59(6):794-9.
    19828464
  • Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, Bamlet WR, Barricarte A, Bingham SA, Boeing H, Boutron-Ruault MC, Buring JE, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Hutchinson A, Jacobs KB, Kraft P, Lynch SM, Manjer J, Manson JE, McTiernan A, McWilliams RR, Mendelsohn JB, Michaud DS, Palli D, Rohan TE, Slimani N, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A, Patel AV, .Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).Arch Intern Med. 2010 May 10;170(9):791-802.
    20458087
  • Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S.HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Am J Pathol. 2010 May;176(5):2292-301.
    20363910
  • Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, .Gastric cancer.J Natl Compr Canc Netw. 2010 Apr;8(4):378-409.
    20410333
  • Firestein R, Shima K, Nosho K, Irahara N, Baba Y, Bojarski E, Giovannucci EL, Hahn WC, Fuchs CS, Ogino S.CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.Int J Cancer. 2010 Jun 15;126(12):2863-73.
    19790197
  • Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, Ogino S.Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.Cancer Causes Control. 2010 Mar;21(3):331-45.
    19936946
  • Lee JE, Giovannucci E, Fuchs CS, Willett WC, Zeisel SH, Cho E.Choline and betaine intake and the risk of colorectal cancer in men.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):884-7.
    20160273
  • Baba Y, Nosho K, Shima K, Goessling W, Chan AT, Ng K, Chan JA, Giovannucci EL, Fuchs CS, Ogino S.PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):822-31.
    20200425
  • Irahara N, Nosho K, Baba Y, Shima K, Lindeman NI, Hazra A, Schernhammer ES, Hunter DJ, Fuchs CS, Ogino S.Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells.J Mol Diagn. 2010 Mar;12(2):177-83.
    20093385
  • Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Li D, Mandelson MT, Olson SH, Risch HA, Zheng W, Albanes D, Bamlet WR, Berg CD, Boutron-Ruault MC, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hassan M, Howard B, Hunter DJ, Hutchinson A, Jenab M, Kaaks R, Kooperberg C, Krogh V, Kurtz RC, Lynch SM, McWilliams RR, Mendelsohn JB, Michaud DS, Parikh H, Patel AV, Peeters PH, Rajkovic A, Riboli E, Rodriguez L, Seminara D, Shu XO, Thomas G, Tjønneland A, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wang Z, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Fraumeni JF, Hoover RN, Hartge P, Chanock SJ.A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.Nat Genet. 2010 Mar;42(3):224-8.
    20101243
  • Bao Y, Spiegelman D, Li R, Giovannucci E, Fuchs CS, Michaud DS.History of peptic ulcer disease and pancreatic cancer risk in men.Gastroenterology. 2010 Feb;138(2):541-9.
    19818786
  • Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Mino-Kenudson M, Giovannucci EL, Meyerhardt JA, Fuchs CS.Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.Am J Gastroenterol. 2010 Feb;105(2):420-33.
    19809407
  • Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H, Clark JW, Abrams TA, Chan JA, Enzinger PC, Bhargava P, Kwak EL, Allen JN, Jain SR, Stuart K, Horgan K, Sheehan S, Fuchs CS, Ryan DP, Sahani DV.Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.Lancet Oncol. 2010 Jan;11(1):48-54.
    19932054
  • Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Anderson G, Boutron-Ruault MC, Buring JE, Canzian F, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hallmans G, Hankinson SE, Hoover RN, Hunter DJ, Hutchinson A, Jacobs K, Kooperberg C, Lynch SM, Mendelsohn JB, Michaud DS, Overvad K, Patel AV, Rajkovic A, Sanchéz MJ, Shu XO, Slimani N, Thomas G, Tobias GS, Trichopoulos D, Vineis P, Virtamo J, Wactawski-Wende J, Yu K, Zeleniuch-Jacquotte A, Hartge P, Fuchs CS.Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.Cancer Res. 2010 Feb 1;70(3):1015-23.
    20103627
  • Engstrom PF, Arnoletti JP, Benson AB, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy MF, Rohren E, Ryan DP, Saltz L, Shibata D, Skibber JM, Small W, Sofocleous C, Thomas J, Venook AP, Willett C, .NCCN clinical practice guidelines in oncology. Anal carcinoma.J Natl Compr Canc Netw. 2010 Jan;8(1):106-20.
    20064293
  • Kesavan Y, Giovannucci E, Fuchs CS, Michaud DS.A prospective study of magnesium and iron intake and pancreatic cancer in men.Am J Epidemiol. 2010 Jan 15;171(2):233-41.
    20022893
  • Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS.Physical activity and male colorectal cancer survival.Arch Intern Med. 2009 Dec 14;169(22):2102-8.
    20008694
  • Ogino S, Meyerhardt JA, Irahara N, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, Hantel A, Benson AB, Goldberg RM, Bertagnolli MM, Fuchs CS, , , , .KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.Clin Cancer Res. 2009 Dec 1;15(23):7322-9.
    19934290
  • Wu K, Platz EA, Willett WC, Fuchs CS, Selhub J, Rosner BA, Hunter DJ, Giovannucci E.A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.Am J Clin Nutr. 2009 Dec;90(6):1623-31.
    19864409
  • Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.Gastroenterology. 2009 Nov;137(5):1609-20.e1-3.
    19686742
  • Jacobson BC,Chan AT,Giovannucci EL,Fuchs CS.Body Mass Index and Barrett's Oesophagus in Women.Gut. 2009 Nov;58(11):1460-6.
    19336423
  • Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N, Dranoff G, Giovannucci EL, Fuchs CS.Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.Clin Cancer Res. 2009 Oct 15;15(20):6412-20.
    19825961
  • Kure S, Nosho K, Baba Y, Irahara N, Shima K, Ng K, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2765-72.
    19789368
  • Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Meyerhardt JA, Fuchs CS.Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.J Clin Oncol. 2009 Sep 20;27(27):4591-8.
    19704056
  • Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA.Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study.Am J Epidemiol. 2009 Oct 1;170(7):863-72.
    19723749
  • Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, .NCCN Clinical Practice Guidelines in Oncology: rectal cancer.J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.
    19755047
  • Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, .NCCN Clinical Practice Guidelines in Oncology: colon cancer.J Natl Compr Canc Netw. 2009 Sep;7(8):778-831.
    19755046
  • Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS.Interaction of molecular markers and physical activity on mortality in patients with colon cancer.Clin Cancer Res. 2009 Sep 15;15(18):5931-6.
    19723652
  • Ogino S, Nosho K, Shima K, Baba Y, Irahara N, Kirkner GJ, Hazra A, De Vivo I, Giovannucci EL, Meyerhardt JA, Fuchs CS.p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21.
    19723919
  • Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, Berrino F, Bingham S, Buring JE, Bracci PM, Canzian F, Clavel-Chapelon F, Clipp S, Cotterchio M, de Andrade M, Duell EJ, Fox JW, Gallinger S, Gaziano JM, Giovannucci EL, Goggins M, González CA, Hallmans G, Hankinson SE, Hassan M, Holly EA, Hunter DJ, Hutchinson A, Jackson R, Jacobs KB, Jenab M, Kaaks R, Klein AP, Kooperberg C, Kurtz RC, Li D, Lynch SM, Mandelson M, McWilliams RR, Mendelsohn JB, Michaud DS, Olson SH, Overvad K, Patel AV, Peeters PH, Rajkovic A, Riboli E, Risch HA, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Van Den Eeden SK, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hartge P, Hoover RN.Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.Nat Genet. 2009 Sep;41(9):986-90.
    19648918
  • Chan AT, Ogino S, Fuchs CS.Aspirin use and survival after diagnosis of colorectal cancer.JAMA. 2009 Aug 12;302(6):649-58.
    19671906
  • Bao Y, Giovannucci E, Fuchs CS, Michaud DS.Passive smoking and pancreatic cancer in women: a prospective cohort study.Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2292-6.
    19602702
  • Ogino S, Nosho K, Baba Y, Kure S, Shima K, Irahara N, Toyoda S, Chen L, Kirkner GJ, Wolpin BM, Chan AT, Giovannucci EL, Fuchs CS.A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.Am J Gastroenterol. 2009 Aug;104(8):2047-56.
    19513025
  • Vora SR, Zheng H, Stadler ZK, Fuchs CS, Zhu AX.Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.Oncologist. 2009 Jul;14(7):717-25.
    19581525
  • Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA.Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.Br J Cancer. 2009 Aug 4;101(3):465-72.
    19603024
  • Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS, Ogino S.Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.Clin Cancer Res. 2009 Jul 15;15(14):4665-73.
    19584150
  • Ogino S, Nosho K, Irahara N, Kure S, Shima K, Baba Y, Toyoda S, Chen L, Giovannucci EL, Meyerhardt JA, Fuchs CS.A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.Clin Cancer Res. 2009 Jul 1;15(13):4431-8.
    19549773
  • Nosho K,Shima K,Irahara N,Kure S,Firestein R,Baba Y,Toyoda S,Chen L,Hazra A,Giovannucci EL,Fuchs CS,Ogino S.SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.Mod Pathol. 2009 Jul;22(7):922-32.
    19430421
  • Zhu AX,Sahani DV,Duda DG,di Tomaso E,Ancukiewicz M,Catalano OA,Sindhwani V,Blaszkowsky LS,Yoon SS,Lahdenranta J,Bhargava P,Meyerhardt J,Clark JW,Kwak EL,Hezel AF,Miksad R,Abrams TA,Enzinger PC,Fuchs CS,Ryan DP,Jain RK.Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study.J Clin Oncol. 2009 Jun 20;27(18):3027-35.
    19470923
  • Ogino S, Shima K, Nosho K, Irahara N, Baba Y, Wolpin BM, Giovannucci EL, Meyerhardt JA, Fuchs CS.A cohort study of p27 localization in colon cancer, body mass index, and patient survival.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1849-58.
    19505918
  • Wark PA, Wu K, van 't Veer P, Fuchs CF, Giovannucci EL.Family history of colorectal cancer: a determinant of advanced adenoma stage or adenoma multiplicity?.Int J Cancer. 2009 Jul 15;125(2):413-20.
    19358277
  • Nosho K,Shima K,Irahara N,Kure S,Baba Y,Kirkner GJ,Chen L,Gokhale S,Hazra A,Spiegelman D,Giovannucci EL,Jaenisch R,Fuchs CS,Ogino S.DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer.Clin Cancer Res. 2009 Jun 1;15(11):3663-3671.
    19470733
  • Baba Y,Nosho K,Shima K,Irahara N,Kure S,Toyoda S,Kirkner GJ,Goel A,Fuchs CS,Ogino S.Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.Neoplasia. 2009 May;11(5):418-25.
    19412426
  • Wolpin BM,Chan AT,Hartge P,Chanock SJ,Kraft P,Hunter DJ,Giovannucci EL,Fuchs CS.ABO blood group and the risk of pancreatic cancer.Journal of the National Cancer Institute. 2009 Mar 18;101(6):424-31.
    19276450
  • Genkinger JM,Spiegelman D,Anderson KE,Bergkvist L,Bernstein L,van den Brandt PA,English DR,Freudenheim JL,Fuchs CS,Giles GG,Giovannucci E,Hankinson SE,Horn-Ross PL,Leitzmann M,Mannisto S,Marshall JR,McCullough ML,Miller AB,Reding DJ,Robien K,Rohan TE,Schatzkin A,Stevens VL,Stolzenberg-Solomon RZ,Verhage BA,Wolk A,Ziegler RG,Smith-Warner SA.Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):765-76.
    19258474
  • Ogino S,Nosho K,Kirkner GJ,Shima K,Irahara N,Kure S,Chan AT,Engelman JA,Kraft P,Cantley LC,Giovannucci EL,Fuchs CS.PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.J Clin Oncol. 2009 Mar 20;27(9):1477-84.
    19237633
  • Ogino S,Shima K,Baba Y,Nosho K,Irahara N,Kure S,Chen L,Toyoda S,Kirkner GJ,Wang YL,Giovannucci EL,Fuchs CS.Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.Gastroenterology. 2009 Apr;136(4):1242-50.
    19186181
  • Kulke MH,Hornick JL,Frauenhoffer C,Hooshmand S,Ryan DP,Enzinger PC,Meyerhardt JA,Clark JW,Stuart K,Fuchs CS,Redston MS.O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Clin Cancer Res. 2009 Jan 1;15(1):338-45.
    19118063
  • Nosho K,Shima K,Kure S,Irahara N,Baba Y,Chen L,Kirkner GJ,Fuchs CS,Ogino S.JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.Neoplasia. 2009 Jan;11(1):87-95.
    19107235
  • Ogino S,Kirkner GJ,Nosho K,Irahara N,Kure S,Shima K,Hazra A,Chan AT,Dehari R,Giovannucci EL,Fuchs CS.Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer.Clin Cancer Res. 2008 Dec 15;14(24):8221-7.
    19088039
  • Fuchs CS,Goldberg RM,Sargent DJ,Meyerhardt JA,Wolpin BM,Green EM,Pitot HC,Pollak M.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.Clin Cancer Res. 2008 Dec 15;14(24):8263-9.
    19073970
  • Wolpin BM,Meyerhardt JA,Chan AT,Ng K,Chan JA,Wu K,Pollak MN,Giovannucci EL,Fuchs CS.Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.J Clin Oncol. 2009 Jan 10;27(2):176-85.
    19064975
  • Wolpin BM,Hezel AF,Abrams T,Blaszkowsky LS,Meyerhardt JA,Chan JA,Enzinger PC,Allen B,Clark JW,Ryan DP,Fuchs CS.Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.J Clin Oncol. 2009 Jan 10;27(2):193-8.
    19047305
  • Ogino S,Nosho K,Kirkner GJ,Kawasaki T,Chan AT,Schernhammer ES,Giovannucci EL,Fuchs CS.A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.Journal of the National Cancer Institute. 2008 Dec 3;100(23):1734-8.
    19033568
  • Nosho K,Irahara N,Shima K,Kure S,Kirkner GJ,Schernhammer ES,Hazra A,Hunter DJ,Quackenbush J,Spiegelman D,Giovannucci EL,Fuchs CS,Ogino S.Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.PLoS ONE. 2008;3(11):e3698.
    19002263
  • Sanoff HK,Sargent DJ,Campbell ME,Morton RF,Fuchs CS,Ramanathan RK,Williamson SK,Findlay BP,Pitot HC,Goldberg RM.Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.J Clin Oncol. 2008 Dec 10;26(35):5721-7.
    19001325
  • Nosho K, Kawasaki T, Chan AT, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.Histopathology. 2008 Nov;53(5):588-98.
    18983468
  • Ogino S,Nosho K,Meyerhardt JA,Kirkner GJ,Chan AT,Kawasaki T,Giovannucci EL,Loda M,Fuchs CS.Cohort study of fatty acid synthase expression and patient survival in colon cancer.J Clin Oncol. 2008 Dec 10;26(35):5713-20.
    18955444
  • Ajani JA,Barthel JS,Bekaii-Saab T,Bentrem DJ,D'Amico TA,Fuchs CS,Gerdes H,Hayman JA,Hazard L,Ilson DH,Kleinberg LR,McAleer MF,Meropol NJ,Mulcahy MF,Orringer MB,Osarogiagbon RU,Posey JA,Sasson AR,Scott WJ,Shibata S,Strong VE,Swisher SG,Washington MK,Willett C,Wood DE,Wright CD,Yang G.Esophageal cancer.J Natl Compr Canc Netw. 2008 Oct;6(9):818-49.
    18926093
  • Schernhammer ES,Giovannuccci E,Fuchs CS,Ogino S.A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status.Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2895-8.
    18843035
  • Ogino S,Nosho K,Kirkner GJ,Kawasaki T,Meyerhardt JA,Loda M,Giovannucci EL,Fuchs CS.CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.Gut. 2009 Jan;58(1):90-6.
    18832519
  • Nanda A,Mamon HJ,Fuchs CS.Sign of Leser-Trelat in newly diagnosed advanced gastric adenocarcinoma.J Clin Oncol. 2008 Oct 20;26(30):4992-3.
    18809604
  • Firestein R,Bass AJ,Kim SY,Dunn IF,Silver SJ,Guney I,Freed E,Ligon AH,Vena N,Ogino S,Chheda MG,Tamayo P,Finn S,Shrestha Y,Boehm JS,Jain S,Bojarski E,Mermel C,Barretina J,Chan JA,Baselga J,Tabernero J,Root DE,Fuchs CS,Loda M,Shivdasani RA,Meyerson M,Hahn WC.CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.Nature. 2008 Sep 25;455(7212):547-51.
    18794900
  • Meyerhardt JA,Niedzwiecki D,Hollis D,Saltz LB,Mayer RJ,Nelson H,Whittom R,Hantel A,Thomas J,Fuchs CS.Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.J Clin Oncol. 2008 Sep 1;26(25):4109-15.
    18757324
  • Schernhammer ES,Ogino S,Fuchs CS.Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.Gastroenterology. 2008 Sep;135(3):770-80.
    18619459
  • Kulke MH,Lenz HJ,Meropol NJ,Posey J,Ryan DP,Picus J,Bergsland E,Stuart K,Tye L,Huang X,Li JZ,Baum CM,Fuchs CS.Activity of sunitinib in patients with advanced neuroendocrine tumors.J Clin Oncol. 2008 Jul 10;26(20):3403-10.
    18612155
  • Wolpin BM,Wei EK,Ng K,Meyerhardt JA,Chan JA,Selhub J,Giovannucci EL,Fuchs CS.Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.J Clin Oncol. 2008 Jul 1;26(19):3222-8.
    18591557
  • Ng K,Meyerhardt JA,Wu K,Feskanich D,Hollis BW,Giovannucci EL,Fuchs CS.Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.J Clin Oncol. 2008 Jun 20;26(18):2984-91.
    18565885
  • Schernhammer ES, Ogino S, Fuchs CS.Folate and Vitamin B(6) Intake and Risk of Colon Cancer in Relation to p53 Expression.Gastroenterology..
  • Thygesen LC,Gronbaek M,Johansen C,Fuchs CS,Willett WC,Giovannucci E.Prospective weight change and colon cancer risk in male US health professionals.Int J Cancer. 2008 Sep 1;123(5):1160-5.
    18546286
  • Chan JA,Meyerhardt JA,Niedzwiecki D,Hollis D,Saltz LB,Mayer RJ,Thomas J,Schaefer P,Whittom R,Hantel A,Goldberg RM,Warren RS,Bertagnolli M,Fuchs CS.Association of family history with cancer recurrence and survival among patients with stage III colon cancer.JAMA. 2008 Jun 4;299(21):2515-23.
    18523220
  • Nosho K,Kawasaki T,Ohnishi M,Suemoto Y,Kirkner GJ,Zepf D,Yan L,Longtine JA,Fuchs CS,Ogino S.PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.Neoplasia. 2008 Jun;10(6):534-41.
    18516290
  • Hazra A,Fuchs CS,Chan AT,Giovannucci EL,Hunter DJ.Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.Cancer Causes Control. 2008 Nov;19(9):975-80.
    18478343
  • Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA.The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.PLoS ONE. 2008;3(4):e2020.
    18414679
  • Ogino S,Kawasaki T,Nosho K,Ohnishi M,Suemoto Y,Kirkner GJ,Fuchs CS.LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.Int J Cancer. 2008 Jun 15;122(12):2767-73.
    18366060
  • Thygesen LC, Wu K, Gronbaek M, Fuchs CS, Willett WC, Giovannucci E.Alcohol intake and colorectal cancer: a comparison of approaches for including repeated measures of alcohol consumption.Epidemiology. 2008 Mar;19(2):258-64.
    18300715
  • Hazra A, Chanock S, Giovannucci E, Cox DG, Niu T, Fuchs C, Willett WC, Hunter DJ.Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):311-9.
    18268114
  • Fuchs CS, Marshall J, Barrueco J.Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study.J Clin Oncol. 2008 Feb 1;26(4):689-90.
    18235136
  • Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Glickman JN, Chan AT, Kirkner GJ, Mino-Kenudson M, Fuchs CS, Ogino S.Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.BMC Cancer. 2008;8:33.
    18230181
  • Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS.Family history and survival after colorectal cancer diagnosis.Cancer. 2008 Mar 15;112(6):1222-9.
    18219663
  • Meyerhardt JA, Zhu AX, Stuart K, Ryan DP, Blaszkowsky L, Lehman N, Earle CC, Kulke MH, Bhargava P, Fuchs CS.Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer.Dig Dis Sci. 2008 Feb;53(2):564-70.
    17597402
  • Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S.CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.Mod Pathol. 2008 Mar;21(3):245-55.
    18204436
  • Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS, Ogino S.IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.Neoplasia. 2007 Dec;9(12):1091-8.
    18084616
  • Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Liu Z, Yamamoto H, Loda M, Fuchs CS, Ogino S.WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.Mod Pathol. 2008 Feb;21(2):150-8.
    18084250
  • Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS.Aspirin dose and duration of use and risk of colorectal cancer in men.Gastroenterology. 2008 Jan;134(1):21-8.
    18005960
  • Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP.Rectal cancer.J Natl Compr Canc Netw. 2007 Oct;5(9):940-81.
    17977503
  • Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP.Colon cancer.J Natl Compr Canc Netw. 2007 Oct;5(9):884-925.
    17977501
  • Fuchs CS, Marshall J, Mitchell E, Wierzbicki R, Ganju V, Jeffery M, Schulz J, Richards D, Soufi-Mahjoubi R, Wang B, Barrueco J.Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.J Clin Oncol. 2007 Oct 20;25(30):4779-86.
    17947725
  • Kulke MH, Blaszkowsky LS, Ryan DP, Clark JW, Meyerhardt JA, Zhu AX, Enzinger PC, Kwak EL, Muzikansky A, Lawrence C, Fuchs CS.Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.J Clin Oncol. 2007 Oct 20;25(30):4787-92.
    17947726
  • Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS.Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.Gut. 2007 Nov;56(11):1564-71.
    17339237
  • Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS.Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2101-9.
    17905943
  • Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.Carcinogenesis. 2007 Sep;28(9):1985-90.
    17621591
  • Koushik A, Hunter DJ, Spiegelman D, Beeson WL, van den Brandt PA, Buring JE, Calle EE, Cho E, Fraser GE, Freudenheim JL, Fuchs CS, Giovannucci EL, Goldbohm RA, Harnack L, Jacobs DR Jr, Kato I, Krogh V, Larsson SC, Leitzmann MF, Marshall JR, McCullough ML, Miller AB, Pietinen P, Rohan TE, Schatzkin A, Sieri S, Virtanen MJ, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Smith-Warner SA.Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies.Journal of the National Cancer Institute. 2007 Oct 3;99(19):1471-83.
    17895473
  • Wolin KY, Lee IM, Colditz GA, Glynn RJ, Fuchs C, Giovannucci E.Leisure-time physical activity patterns and risk of colon cancer in women.Int J Cancer. 2007 Dec 15;121(12):2776-81.
    17722094
  • Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Dehari R, Meyerhardt JA, Fuchs CS, Ogino S.Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.Neoplasia. 2007 Jul;9(7):569-77.
    17710160
  • Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS.Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.JAMA. 2007 Aug 15;298(7):754-64.
    17699009
  • Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS.Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.Cancer Res. 2007 Aug 15;67(16):7923-8.
    17699799
  • Wang F, Wang L, Briggs C, Sicinska E, Gaston SM, Mamon H, Kulke MH, Zamponi R, Loda M, Maher E, Ogino S, Fuchs CS, Li J, Hader C, Makrigiorgos GM.DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.J Mol Diagn. 2007 Sep;9(4):441-51.
    17690213
  • Meyerhardt JA, Clark JW, Supko JG, Eder JP, Ogino S, Stewart CF, D'Amato F, Dancey J, Enzinger PC, Zhu AX, Ryan DP, Earle CC, Mayer RJ, Michelini A, Kinsella K, Fuchs CS.Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.Cancer Chemother Pharmacol. 2007 Oct;60(5):661-70.
    17216531
  • Cho E, Willett WC, Colditz GA, Fuchs CS, Wu K, Chan AT, Zeisel SH, Giovannucci EL.Dietary choline and betaine and the risk of distal colorectal adenoma in women.J Natl Cancer Inst. 2007 Aug 15;99(16):1224-31.
    17686825
  • Meyerhardt J, Stuart K, Fuchs C, Zhu A, Earle C, Bhargava P, Blaszkowsky L, Enzinger P, Mayer R, Battu S, Lawrence C, Ryan D.Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer.Ann Oncol. 2007 Jul;18(7):1185-9.
    17483115
  • Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ.Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.Carcinogenesis. 2007 Jul;28(7):1510-9.
    17389618
  • Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL.A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.Journal of the National Cancer Institute. 2007 Jul 18;99(14):1120-9.
    17623801
  • Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.J Mol Diagn. 2007 Jul;9(3):305-14.
    17591929
  • Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS.Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.Br J Cancer. 2007 Jul 2;97(1):98-104.
    17533398
  • Zhu AX, Stuart K, Blaszkowsky LS, Muzikansky A, Reitberg DP, Clark JW, Enzinger PC, Bhargava P, Meyerhardt JA, Horgan K, Fuchs CS, Ryan DP.Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.Cancer. 2007 Aug 1;110(3):581-9.
    17583545
  • Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C.Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.Cancer Res. 2007 Jun 1;67(11):5553-60.
    17545639
  • Chan AT, Ogino S, Fuchs CS.Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2.N Engl J Med. 2007 May 24;356(21):2131-2142.
    17522398
  • Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Hum Pathol. 2007 Jun;38(6):842-9.
    17350669
  • Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample.J Mol Diagn. 2007 May 3.
    17478565
  • Ogino S, Kawasaki T, Kirkner GJ, Ohnishi M, Fuchs CS.18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated positively with CpG island methylator phenotype-negative (CIMP-negative) and inversely with CIMP-low and CIMP-high.BMC Cancer. 2007 May 2;7(1):72.
    17474983
  • Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS.Impact of hospital volume on recurrence and survival after surgery for gastric cancer.Ann Surg. 2007 Mar;245(3):426-34.
    17435550
  • Chan AT, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS.Long-term aspirin use and mortality in women.Arch Intern Med. 2007 Mar 26;167(6):562-72.
    17389287
  • Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL.Calcium and vitamin d intakes in relation to risk of distal colorectal adenoma in women.Am J Epidemiol. 2007 May 15;165(10):1178-86.
    17379616
  • Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, Enzinger PC, Wolpin BM, Loda M, Fuchs CS.CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.Virchows Arch. 2007 May;450(5):529-537.
    17372756
  • Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.Hum Pathol. 2007 Apr;38(4):614-20.
    17270239
  • Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.Hum Pathol. 2007 Apr;38(4):585-92.
    17239930
  • Michaud DS, Joshipura K, Giovannucci E, Fuchs CS.A prospective study of periodontal disease and pancreatic cancer in US male health professionals.Journal of the National Cancer Institute. 2007 Jan 17;99(2):171-5.
    17228001
  • Chan AT, Ogino S, Fuchs CS.Aspirin use and risk of colorectal cancer according to cyclooxygenase-2 expression.Eval & Prog Plan. 2007;?:in press.
  • Zhu AX, Clark JW, Ryan DP, Meyerhardt JA, Enzinger PC, Earle CC, Fuchs CS, Regan E, Anbe H, Houghton M, Zhang J, Urrea P, Kulke MH.Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.Cancer Chemother Pharmacol. 2007 Feb;59(3):285-93.
    16786333
  • Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS.Hormone replacement therapy and survival after colorectal cancer diagnosis.J Clin Oncol. 2006 Dec 20;24(36):5680-6.
    17179103
  • Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ.Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2408-17.
    17164363
  • Mannisto S, Yaun SS, Hunter DJ, Spiegelman D, Adami HO, Albanes D, van den Brandt PA, Buring JE, Cerhan JR, Colditz GA, Freudenheim JL, Fuchs CS, Giovannucci E, Goldbohm RA, Harnack L, Leitzmann M, McCullough ML, Miller AB, Rohan TE, Schatzkin A, Virtamo J, Willett WC, Wolk A, Zhang SM, Smith-Warner SA.Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies.Am J Epidemiol. 2007 Feb 1;165(3):246-55.
    17158857
  • Goldberg RM, Hurwitz HI, Fuchs CS.The role of targeted therapy in the treatment of colorectal cancer.Clin Adv Hematol Oncol. 2006 Aug;4 Suppl 17(8):1-12. Review.
    17139241
  • Ogino S, Kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS.Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.Mod Pathol. 2007 Jan;20(1):15-22.
    17086168
  • Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.J Mol Diagn. 2006 Nov;8(5):582-8.
    17065427
  • Wolpin BM, Clark JW, Meyerhardt JA, Earle CC, Ryan DP, Enzinger PC, Zhu AX, Blaszkowsky L, Battu S, Fuchs CS.Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancer.Clin Colorectal Cancer. 2006 Sep;6(3):208-13.
    17026790
  • Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS.Vitamin D intake and the risk for pancreatic cancer in two cohort studies.Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95.
    16985031
  • Ogino S, Kawasaki T, Kirkner G, Ogawa A, Dorfman I, Loda M, Fuchs C.Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.J Pathol. 2006 Oct;210(2):147-54.
    16850502
  • Fuchs C, Mitchell EP, Hoff PM.Irinotecan in the treatment of colorectal cancer.Cancer Treat Rev. 2006 Nov;32(7):491-503. Review.
    16959432
  • Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, Giovannucci EL, Hunter DJ.p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer.Int J Cancer. 2006 Oct 15;119(8):1863-8.
    16721787
  • Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS.Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.Am J Surg Pathol. 2006 Sep;30(9):1175-83.
    16931963
  • Lin J, Zhang SM, Wu K, Willett WC, Fuchs CS, Giovannucci E.Flavonoid intake and colorectal cancer risk in men and women.Am J Epidemiol. 2006 Oct 1;164(7):644-51.
    16923774
  • Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS.Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.J Clin Oncol. 2006 Aug 1;24(22):3555-61.
    16877721
  • Kulke MH, Wu B, Ryan DP, Enzinger PC, Zhu AX, Clark JW, Earle CC, Michelini A, Fuchs CS.A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.Dig Dis Sci. 2006 Jun;51(6):1033-8.
    16865563
  • Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL, Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW.Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4283-7.
    16857803
  • Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts S.Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.J Clin Oncol. 2006 Jul 20;24(21):3347-53.
    16849748
  • Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.Mod Pathol. 2006 Aug;19(8):1083-90.
    16699497
  • Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS.Physical activity and survival after colorectal cancer diagnosis.J Clin Oncol. 2006 Aug 1;24(22):3527-34.
    16822844
  • Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS.Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.J Clin Oncol. 2006 Aug 1;24(22):3535-41.
    16822843
  • Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.Neoplasia. 2006 Jun;8(6):458-64.
    16820091
  • Kulke MH, Wu B, Clark JW, Enzinger PC, Lynch TJ, Vincitore M, Michelini A, Fuchs CS.A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.Cancer Invest. 2006 Apr-May;24(3):229-34.
    16809148
  • Meyerhardt JA, Heseltine D, Ogino S, Clark JW, Enzinger PC, Ryan DP, Earle CC, Zhu AX, Fuchs CS.Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer.Clin Colorectal Cancer. 2006 May;6(1):59-65.
    16796793
  • Kulke MH, Muzikansky A, Clark J, Enzinger PC, Fidias P, Kinsella K, Michelini A, Fuchs CS.A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.Cancer Invest. 2006 Jun-Jul;24(4):346-50.
    16777685
  • Wu K, Giovannucci E, Byrne C, Platz EA, Fuchs C, Willett WC, Sinha R.Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men.Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1120-5.
    16775169
  • Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner G, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS.CpG island methylator phenotype (CIMP) of colorectal cancer is best characterized by quantitative DNA methylation analysis and prospective cohort studies.Gut. 2006 Jul;55(7):1000-6.
    16407376
  • Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS.Precision and Performance Characteristics of Bisulfite Conversion and Real-Time PCR (MethyLight) for Quantitative DNA Methylation Analysis.J Mol Diagn. 2006 May;8(2):209-217.
    16645207
  • Tranah GJ, Bugni J, Giovannucci E, Ma J, Fuchs C, Hines L, Samson L, Hunter DJ.O(6)-Methylguanine-DNA Methyltransferase Leu84Phe and Ile143Val Polymorphisms and Risk of Colorectal Cancer in the Nurses' Health Study and Physicians' Health Study (United States).Cancer Causes Control. 2006 Jun;17(5):721-31.
    16633920
  • Meyerhardt JA, Zhu AX, Enzinger PC, Ryan DP, Clark JW, Kulke MH, Earle CC, Vincitore M, Michelini A, Sheehan S, Fuchs CS.Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.J Clin Oncol. 2006 Apr 20;24(12):1892-7.
    16622264
  • Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E.C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):750-5.
    16614119
  • Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, Willett WC.Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study.Cancer Res. 2006 Apr 1;66(7):3942-53.
    16585224
  • Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC.Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.J Natl Cancer Inst. 2006 Apr 5;98(7):451-9.
    16595781
  • Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, Swisher SG, Wood DE, Yen Y.Gastric Cancer Clinical Practice Guidelines.J Natl Compr Canc Netw. 2006 Apr;4(4):350-66.
    16569388
  • Goldberg RM, Hurwitz HI, Fuchs CS.Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.Clin Adv Hematol Oncol. 2005 Dec;3(12):1-10; quiz 11.
    16555433
  • Schernhammer ES, Tranah GJ, Giovannucci E, Chan AT, Ma J, Colditz GA, Hunter DJ, Willett WC, Fuchs CS.Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.Br J Cancer. 2006 Mar 27;94(6):928-34.
    16495921
  • McCollum AD, Wu B, Clark JW, Kulke MH, Enzinger PC, Ryan DP, Earle CC, Michelini A, Fuchs CS.The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.Am J Clin Oncol. 2006 Feb;29(1):40-4.
    16462501
  • Kulke MH, Stuart K, Enzinger PC, Ryan DP, Clark JW, Muzikansky A, Vincitore M, Michelini A, Fuchs CS.Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.J Clin Oncol. 2006 Jan 20;24(3):401-6.
    16421420
  • Enzinger PC, Kulke MH, Clark JW, Ryan DP, Kim H, Earle CC, Vincitore MM, Michelini AL, Mayer RJ, Fuchs CS.A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma.Dig Dis Sci. 2005 Dec;50(12):2218-23.
    16416165
  • Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS.Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.Mod Pathol. 2006 Jan;19(1):59-68.
    16118624
  • Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, van den Brandt PA, Buring JE, Colditz GA, Freudenheim JL, Fuchs CS, Giovannucci E, Goldbohm RA, Graham S, Harnack L, Hartman AM, Jacobs DR Jr, Kato I, Krogh V, Leitzmann MF, McCullough ML, Miller AB, Pietinen P, Rohan TE, Schatzkin A, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Smith-Warner SA.Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies.JAMA. 2005 Dec 14;294(22):2849-57.
    16352792
  • Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS.Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8453-60.
    16293876
  • Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS.Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.J Natl Cancer Inst. 2005 Nov 16;97(22):1688-94.
    16288122
  • Michaud DS, Fuchs CS.Obesity and pancreatic cancer: overall evidence and latency period.Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2678; author reply 2678-9.
    16284397
  • Kroenke CH, Bennett GG, Fuchs C, Giovannucci E, Kawachi I, Schernhammer E, Holmes MD, Kubzansky LD.Depressive symptoms and prospective incidence of colorectal cancer in women.Am J Epidemiol. 2005 Nov 1;162(9):839-48.
    16207809
  • Flaherty KT, Fuchs CS, Colditz GA, Stampfer MJ, Speizer FE, Willett WC, Curhan GC.A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States).Cancer Causes Control. 2005 Nov;16(9):1099-106.
    16184476
  • Hillner BE, Schrag D, Sargent DJ, Fuchs CS, Goldberg RM.Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.Cancer. 2005 Nov 1;104(9):1871-84.
    16177989
  • Schernhammer ES, Hu FB, Giovannucci E, Michaud DS, Colditz GA, Stampfer MJ, Fuchs CS.Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts.Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2098-105.
    16172216
  • Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS.Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.Clin Cancer Res. 2005 Sep 15;11(18):6650-6.
    16166444
  • Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.JAMA. 2005 Aug 24;294(8):914-23.
    16118381
  • Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM, Cress RD, O'Connor LC, West DW, Wright WE.Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language.J Clin Oncol. 2005 Sep 20;23(27):6576-86.
    16116149
  • Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS.Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.J Mol Diagn. 2005 Aug;7(3):413-21.
    16049314
  • Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ,.Anal canal cancer clinical practice guidelines in oncology.J Natl Compr Canc Netw. 2005 Jul;3(4):510-5.
    16038641
  • Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg DJ, Pollak M, Morton RK, Williamson SK, Findlay BP, Fuchs CS.The associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.J Am Diet Assoc. In press;In press:In press.
  • Tranah GJ, Chan AT, Giovannucci E, Fuchs C, Ma J, Hunter DJ.Epoxide Hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses Health Study and the Physicians Health Study.Mol Carcinog. In press;In press:In press.
  • Zhu AX, Fuchs CS, Clark JW, Muzikansky A, Taylor K, Sheehan S, Tam K, Yung E, Kulke MH, Ryan DP.A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.Oncologist. 2005 Jun-Jul;10(6):392-8.
    15967833
  • Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs CS.Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.J Natl Cancer Inst. 2005 Jun 15;97(12):917-26.
    15956653
  • Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg RM, Pollak M, Morton RF, Ramanathan RK, Williamson SK, Findlay BP, Fuchs CS.Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1402-10.
    15941948
  • Tranah GJ, Chan AT, Giovannucci E, Ma J, Fuchs C, Hunter DJ.Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.Mol Carcinog. 2005 Sep;44(1):21-30.
    15924351
  • Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J.Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.J Natl Cancer Inst. 2005 May 4;97(9):684-92.
    15870439
  • Oh K, Willett WC, Fuchs CS, Giovannucci E.Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):835-41.
    15824153
  • Michels KB, Fuchs CS, Giovannucci E, Colditz GA, Hunter DJ, Stampfer MJ, Willett WC.Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):842-9.
    15824154
  • Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ.APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):863-70.
    15824157
  • Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E.A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):850-5.
    15824155
  • Michaud DS, Skinner HG, Wu K, Hu F, Giovannucci E, Willett WC, Colditz GA, Fuchs CS.Dietary patterns and pancreatic cancer risk in men and women.J Natl Cancer Inst. 2005 Apr 6;97(7):518-24.
    15812077
  • Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS.Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.J Natl Cancer Inst. 2005 Mar 16;97(6):457-60.
    15770010
  • Michels KB, Willett WC, Fuchs CS, Giovannucci E.Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.J Natl Cancer Inst. 2005 Feb 16;97(4):282-92.
    15713963
  • Chan AT, Tranah GJ, Giovannucci EL, Willett WC, Hunter DJ, Fuchs CS.Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer.Int J Cancer. 2005 Jul 1;115(4):648-52.
    15700302
  • Meyerhardt JA, Fuchs CS.Epidermal growth factor receptor inhibitors and colorectal cancer.Oncology (Huntingt). 2004 Dec;18(14 Suppl 14):35-8.
    15685832
  • Delaunoit T, Alberts SR, Sargent DJ, Green E, Goldberg RM, Krook J, Fuchs C, Ramanathan RK, Williamson SK, Morton RF, Findlay BP.Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.Ann Oncol. 2005 Mar;16(3):425-9.
    15677624
  • Michaud DS, Fuchs CS, Liu S, Willett WC, Colditz GA, Giovannucci E.Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women.Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):138-47.
    15668487
  • Chen J, Kyte C, Chan W, Wetmur JG, Fuchs CS, Giovannucci E.Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas.Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2247-50.
    15598787
  • McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS.Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.Am J Clin Oncol. 2004 Oct;27(5):485-8.
    15596916
  • Wu K, Hu FB, Fuchs C, Rimm EB, Willett WC, Giovannucci E.Dietary patterns and risk of colon cancer and adenoma in a cohort of men (United States).Cancer Causes Control. 2004 Nov;15(9):853-62.
    15577287
  • Earle CC, Kwok A, Gazelle GS, Fuchs CS.Two schedules of second-line irinotecan for metastatic colon carcinoma.Cancer. 2004 Dec 1;101(11):2533-9.
    15503310
  • Kulke MH, Kim H, Stuart K, Clark JW, Ryan DP, Vincitore M, Mayer RJ, Fuchs CS.A phase II study of docetaxel in patients with metastatic carcinoid tumors.Cancer Invest. 2004;22(3):353-9.
    15493355
  • Delaunoit T, Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Findlay BP, Thomas SP, Salim M, Schaefer PL, Stella PJ, Green E, Mailliard JA.Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.Cancer. 2004 Nov 15;101(10):2170-6.
    15470715
  • Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL.Plasma vitamin D metabolites and risk of colorectal cancer in women.Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1502-8.
    15342452
  • Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS.A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.Cancer. 2004 Sep 1;101(5):934-9.
    15329900
  • Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS.A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.Clin Gastroenterol Hepatol. 2004 Aug;2(8):704-12.
    15290664
  • Oh K, Willett WC, Fuchs CS, Giovannucci EL.Glycemic index, glycemic load, and carbohydrate intake in relation to risk of distal colorectal adenoma in women.Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1192-8.
    15247130
  • Meyerhardt JA, Kwok A, Ratain MJ, McGovren JP, Fuchs CS.Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer.J Clin Oncol. 2004 Apr 15;22(8):1439-46.
    15084617
  • Ryan DP, Eder JP, Puchlaski T, Seiden MV, Lynch TJ, Fuchs CS, Amrein PC, Sonnichsen D, Supko JG, Clark JW.Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors.Clin Cancer Res. 2004 Apr 1;10(7):2222-30.
    15073096
  • Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE.A prospective study of dietary lactose and ovarian cancer.Int J Cancer. 2004 Jun 10;110(2):271-7.
    15069693
  • Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS.A prospective study of aspirin use and the risk for colorectal adenoma.Ann Intern Med. 2004 Feb 3;140(3):157-66.
    14757613
  • Schernhammer ES, Kang JH, Chan AT, Michaud DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS.A prospective study of aspirin use and the risk of pancreatic cancer in women.J Natl Cancer Inst. 2004 Jan 7;96(1):22-8.
    14709735
  • Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, MacDonald JS, Benson AB, Fuchs CS.Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.J Clin Oncol. 2004 Jan 1;22(1):166-74.
    14701779
  • Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, Colditz GA.Comparison of risk factors for colon and rectal cancer.Int J Cancer. 2004 Jan 20;108(3):433-42.
    14648711
  • Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ.Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):970-9.
    14578131
  • Meyerhardt JA, Catalano PJ, Schrag D, Ayanian JZ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS.Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.Ann Intern Med. 2003 Oct 21;139(8):649-57.
    14568853
  • Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ.A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.Cancer Invest. 2003;21(4):505-11.
    14533439
  • Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB, Macdonald JS, Fuchs CS.Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.Cancer. 2003 Aug 1;98(3):484-95.
    12879464
  • Meyerhardt JA, Fuchs CS.Adjuvant therapy in gastric cancer: can we prevent recurrences?.Oncology (Huntingt). 2003 May;17(5):714-21, 728; discussion 7.
    12800796
  • Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS.Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study.Am J Epidemiol. 2003 Jun 15;157(12):1115-25.
    12796048
  • Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA.Night-shift work and risk of colorectal cancer in the nurses' health study.J Natl Cancer Inst. 2003 Jun 4;95(11):825-8.
    12783938
  • Hodgson DC, Zhang W, Zaslavsky AM, Fuchs CS, Wright WE, Ayanian JZ.Relation of hospital volume to colostomy rates and survival for patients with rectal cancer.J Natl Cancer Inst. 2003 May 21;95(10):708-16.
    12759388
  • Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, O'Connor LC, West DW, Allen ME, Wolf RE, Wright WE.Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.J Clin Oncol. 2003 Apr 1;21(7):1293-300.
    12663717
  • Fuchs CS, Moore MR, Harker G, Villa L, Rinaldi D, Hecht JR.Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.J Clin Oncol. 2003 Mar 1;21(5):807-14.
    12610178
  • Fung T, Hu FB, Fuchs C, Giovannucci E, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC.Major dietary patterns and the risk of colorectal cancer in women.Arch Intern Med. 2003 Feb 10;163(3):309-14.
    12578511
  • Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS.Impact of diabetes mellitus on outcomes in patients with colon cancer.J Clin Oncol. 2003 Feb 1;21(3):433-40.
    12560431
  • Michaelson MD, Ryan DP, Fuchs CS, Supko JG, Garcia-Carbonero R, Paul Eder J, Clark JW.A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.Cancer. 2003 Jan 1;97(1):148-54.
    12491516
  • Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS.A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.Cancer J. 2002 Sep-Oct;8(5):395-9.
    12416897
  • Michaud DS, Liu S, Giovannucci E, Willett WC, Colditz GA, Fuchs CS.Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study.J Natl Cancer Inst. 2002 Sep 4;94(17):1293-300.
    12208894
  • Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE.Aspirin, other NSAIDs, and ovarian cancer risk (United States).Cancer Causes Control. 2002 Aug;13(6):535-42.
    12195643
  • McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS.Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.J Natl Cancer Inst. 2002 Aug 7;94(15):1160-7.
    12165641
  • Fuchs CS, Clark JW, Ryan DP, Kulke MH, Kim H, Earle CC, Vincitore M, Mayer RJ, Stuart KE.A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.Cancer. 2002 Jun 15;94(12):3186-91.
    12115351
  • Jeter MD, Jnne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R.Gemcitabine-induced radiation recall.Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):394-400.
    12023144
  • Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL.Calcium intake and risk of colon cancer in women and men.J Natl Cancer Inst. 2002 Mar 20;94(6):437-46.
    11904316
  • You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA.Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1455-60.
    11818530
  • Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS.Physical activity, obesity, height, and the risk of pancreatic cancer.JAMA. 2001 Aug 22-29;286(8):921-9.
    11509056
  • Bertone ER, Willett WC, Rosner BA, Hunter DJ, Fuchs CS, Speizer FE, Colditz GA, Hankinson SE,.Prospective study of recreational physical activity and ovarian cancer.J Natl Cancer Inst. 2001 Jun 20;93(12):942-8.
    11416116
  • Michels KB, Edward Giovannucci , Joshipura KJ, Rosner BA, Stampfer MJ, Fuchs CS, Colditz GA, Speizer FE, Willett WC.Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers.J Natl Cancer Inst. 2000 Nov 1;92(21):1740-52.
    11058617
  • Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.Cost-effectiveness of screening for colorectal cancer in the general population.JAMA. 2000 Oct 18;284(15):1954-61.
    11035892
  • Dukas L, Willett WC, Colditz GA, Fuchs CS, Rosner B, Giovannucci EL.Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women.Am J Epidemiol. 2000 May 15;151(10):958-64.
    10853634
  • Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW.A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.Cancer. 2000 Jan 1;88(1):180-5.
    10618622
  • Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC.Dietary fiber and the risk of colorectal cancer and adenoma in women.N Engl J Med. 1999 Jan 21;340(3):169-76.
    9895396
  • Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WC.Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.Ann Intern Med. 1998 Oct 1;129(7):517-24.
    9758570
  • Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, Rimm EB, Willett WC, Speizer FE.A prospective study of cigarette smoking and the risk of pancreatic cancer.Arch Intern Med. 1996 Oct 28;156(19):2255-60.
    8885826
  • Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC.A prospective study of family history and the risk of colorectal cancer.N Engl J Med. 1994 Dec 22;331(25):1669-74.
    7969357